利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

77 条记录 (耗时 0.032 秒)

    Molded materials based on polycarbonates
    4.
    发明授权
    Molded materials based on polycarbonates 失效
    基于聚碳酸酯的成型材料

    公开(公告)号：US5969016A

    公开(公告)日：1999-10-19

    申请号：US772127

    申请日：1996-12-20

    申请人： Martin Weber ,  Robert Weiss ,  Norbert Guntherberg ,  Klemens Massonne ,  Joachim Seibring ,  Guenther Zimmer

    发明人： Martin Weber ,  Robert Weiss ,  Norbert Guntherberg ,  Klemens Massonne ,  Joachim Seibring ,  Guenther Zimmer

    IPC分类号： C08L25/12 ,  C08L51/04 ,  C08L69/00 ,  C08L71/00 ,  C08L55/02

    CPC分类号： C08L51/04 ,  C08L69/00 ,  C08L25/12 ,  C08L71/00

    摘要： Molding materials containA) from 5 to 97.9% by weight of at least one polycarbonate having a weight average molecular weight (M.sub.w) of from 10,000 to 64,000 g/mol,B) from 1 to 93.9% by weight of at least one graft copolymer,C) from 1 to 93.9% by weight of at least one copolymerc.sub.1) at least one vinylaromatic compound of the general formula I ##STR1## where R is hydrogen or C.sub.1 -C.sub.8 -alkyl, R.sup.1 is C.sub.1 -C.sub.8 -alkyl and n is an integer from 0 to 3, or of a C.sub.1 -C.sub.8 -alkyl acrylate, a C.sub.1 -C.sub.8 -alkyl C.sub.1 -C.sub.8 -alkylacrylate or a mixture thereof and c.sub.2) acrylonitrile, C.sub.1 -C.sub.8 -alkylacrylonitrile or a mixture thereof,D) from 0.01 to 10% by weight of at least one polyhydroxyether of at least one aliphatic or aromatic diol with epihalohydrin,E) from 1 to 25% by weight of at least one halogen-free phosphorus compound andF) from 0 to 50% by weight of additives.

    摘要翻译： 成型材料包含A）5至97.9重量％的至少一种重均分子量（Mw）为10,000至64,000g / mol的聚碳酸酯，B）1至93.9重量％的至少一种接枝共聚物 C）1至93.9重量％的至少一种共聚物c1）至少一种通式I的乙烯基芳族化合物，其中R是氢或C 1 -C 8烷基，R 1是C 1 -C 8 - 烷基，n是整数 丙烯酸C1-C8烷基酯，丙烯酸C1-C8-烷基酯或其混合物，和c2）丙烯腈，C1-C8烷基丙烯腈或其混合物，D）为0.01〜 10重量％的至少一种至少一种脂族或芳族二醇与表卤代醇的聚羟基醚，E）1至25重量％的至少一种无卤素磷化合物和F）0至50重量％的添加剂 。

    Method for printing printed material, which is individualized with logistic print-image elements
    5.
    发明授权
    Method for printing printed material, which is individualized with logistic print-image elements 有权
    用于印刷材料的方法，其以物流印刷图像元素个性化

    公开(公告)号：US08610941B2

    公开(公告)日：2013-12-17

    申请号：US11587871

    申请日：2004-04-30

    申请人： Josef Schneider ,  Reinhard Baumann ,  Peer Dilling ,  Robert Weiss

    发明人： Josef Schneider ,  Reinhard Baumann ,  Peer Dilling ,  Robert Weiss

    IPC分类号： G06K15/00

    CPC分类号： B41F33/0009

    摘要： The invention relates to a method for printing printed material which is individualized with logistical printed image elements, wherein at least one printed image, particularly a static printed image, which is printed in a printing machine, is individualized by technically adding at least one dynamic logistical printed image element. According to the invention, data of the/each dynamic logistical printed image element is combined in such a way that the/each printed image and the/each logistical printed image element are automatically updated by comparing data between a data bank provided by a print job user and a data bank provided by a logistics provider prior to printing the printed material individualized with the/each logistical printed image element.

    摘要翻译： 本发明涉及一种打印材料的方法，该打印材料是个性化的后勤打印图像元素，其中印刷在印刷机中的至少一个印刷图像，特别是静态印刷图像通过技术上添加至少一个动态后勤 印刷图像元素。 根据本发明，通过比较由打印作业提供的数据库之间的数据来自动更新/每个动态后勤打印图像元素的数据，使得每个打印图像和/每个后勤打印图像元素被自动更新 用户和由物流提供者提供的数据库，然后打印用/每个后勤打印的图像元素个性化的打印材料。

    Process for Producing Rfid Labels
    6.
    发明申请
    Process for Producing Rfid Labels 审中-公开
    生产Rfid标签的过程

    公开(公告)号：US20080213019A1

    公开(公告)日：2008-09-04

    申请号：US10589214

    申请日：2005-01-28

    申请人： Thomas Walther ,  Reinhard Baumann ,  Robert Weiss ,  Peer Dilling

    发明人： Thomas Walther ,  Reinhard Baumann ,  Robert Weiss ,  Peer Dilling

    IPC分类号： B41J11/44

    CPC分类号： H05K3/12 ,  B41F17/00 ,  B41M1/22 ,  G06K19/07749 ,  G06K19/07758 ,  G06K19/0776 ,  H01L51/0004 ,  H05K3/1275 ,  H05K2203/0534 ,  H05K2203/1545 ,  H05K2203/161

    摘要： The invention relates to a method for producing an RFID label using a printing method. The aim of the invention is to apply the required parts to the label in a simple manner, and preferably also to protect the antenna from mechanical damage. To this end, at least part of the antenna required for the operation of the label and part of the oscillating circuit is applied to the stock by means of sheet-fed offset printing or directly or indirectly by means of a relief-printing plate. In order to protect the oscillating circuit from damage, the application surface thereof is lowered, or the oscillating circuit and the antenna are lowered into the stock after the application process.

    摘要翻译： 本发明涉及使用印刷方法制造RFID标签的方法。 本发明的目的是以简单的方式将所需的部件施加到标签上，并且优选地还用于保护天线免受机械损坏。 为此，将标签和振荡电路的一部分操作所需的天线的至少一部分通过单张胶版印刷或通过凸版印刷板直接或间接地施加到原稿上。 为了保护振荡电路免受损坏，其应用表面降低，或者在施加处理之后将振荡电路和天线放入库存中。

    METHOD AND APPARATUS FOR APPLYING ENERGY TO BIOLOGICAL TISSUE INCLUDING THE USE OF TUMESCENT TISSUE COMPRESSION
    8.
    发明申请
    METHOD AND APPARATUS FOR APPLYING ENERGY TO BIOLOGICAL TISSUE INCLUDING THE USE OF TUMESCENT TISSUE COMPRESSION 审中-公开
    用于将能量应用于生物组织的方法和装置，包括使用肿瘤组织压缩

    公开(公告)号：US20080039793A1

    公开(公告)日：2008-02-14

    申请号：US11841913

    申请日：2007-08-20

    申请人： Mitchel Goldman ,  Robert Weiss ,  Arthur Zikorus ,  James Chandler

    发明人： Mitchel Goldman ,  Robert Weiss ,  Arthur Zikorus ,  James Chandler

    IPC分类号： A61B18/14

    CPC分类号： G02F1/134363 ,  A61B18/1492 ,  A61B2017/22038 ,  A61B2017/22051 ,  A61B2017/22067 ,  A61B2018/00214 ,  A61B2018/0022 ,  A61B2018/00404 ,  A61B2018/00488 ,  A61B2018/00589 ,  A61B2018/00898 ,  A61B2018/124 ,  A61B2018/1253 ,  A61B2018/126 ,  A61B2090/3782 ,  A61B2218/002 ,  G02F1/136213 ,  G02F1/136259 ,  G02F2201/12

    摘要： An electrode catheter is introduced into a hollow anatomical structure, such as a vein, and is positioned at a treatment site within the structure. Tumescent fluid is injected into the tissue surrounding the treatment site to produce tumescence of the surrounding tissue which then compresses the vein. The solution may include an anesthetic, and may further include a vasoconstrictive drug that shrinks blood vessels. The tumescent swelling in the surrounding tissue causes the hollow anatomical structure to become compressed, thereby exsanguinating the treatment site. Energy is applied by an electrode catheter in apposition with the vein wall to create a heating effect. The heating effect causes the hollow anatomical structure to become molded and durably assume the compressed dimensions caused by the tumescent technique. The electrode catheter can be moved within the structure so as to apply energy to a large section of the hollow anatomic structure. In a further aspect, the location of the electrodes is determined by impedance monitoring. Also, temperature sensors at the treatment site are averaged to determine the site temperature.

    摘要翻译： 将电极导管引入到诸如静脉的中空解剖结构中，并且位于结构内的治疗部位。 将肿胀流体注射到处理部位周围的组织中，以产生周围组织的肿胀，然后压缩静脉。 溶液可以包括麻醉剂，并且还可以包括收缩血管的血管收缩药物。 周围组织的肿胀肿胀导致中空的解剖结构变得压缩，从而使治疗部位脱垂。 能量通过电极导管与静脉壁一起施加以产生加热效果。 加热效果使得中空的解剖结构变得模制并且持久地承受由肿胀技术引起的压缩尺寸。 电极导管可以在结构内移动，以将能量施加到中空解剖结构的大部分。 在另一方面，通过阻抗监测确定电极的位置。 此外，将处理部位的温度传感器平均以确定现场温度。

    Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
    9.
    发明申请
    Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure 审中-公开
    改善心肌肌酸激酶代谢和收缩功能治疗心力衰竭的方法

    公开(公告)号：US20070265221A1

    公开(公告)日：2007-11-15

    申请号：US11797835

    申请日：2007-05-08

    申请人： Robert Weiss ,  Hunter Champion

    发明人： Robert Weiss ,  Hunter Champion

    IPC分类号： A61K31/70 ,  A61B5/05

    CPC分类号： A61K38/45 ,  C12N9/1223 ,  C12N15/85 ,  C12Q1/50 ,  G01N2500/02 ,  G01N2800/325

    摘要： The present invention relates to novel treatments of mammalian and human heart failure directed at improving cardiac creatine kinase metabolism, the prime energy reserve of cardiac muscle. The invention also relates to novel treatments using gene transfer vectors to increase myocardial creatine kinase protein expression and/or creatine kinase activity, as well as flux through the creatine kinase reaction and to thereby improve cardiac contractile function and ameliorate remodeling in heart failure. The invention further relates to methods for screening and identifying compounds that increase creatine kinase expression and/or creatine kinase activity as potential pharmaceutical compositions for heart failure therapy.

    摘要翻译： 本发明涉及针对改善心肌肌酸激酶代谢（心肌主要能量储备）的哺乳动物和人心力衰竭的新型治疗。 本发明还涉及使用基因转移载体增加心肌肌酸激酶蛋白表达和/或肌酸激酶活性的新型治疗，以及通过肌酸激酶反应的通量，从而改善心脏收缩功能并改善心力衰竭中的重塑。 本发明还涉及用于筛选和鉴定增加肌酸激酶表达和/或肌酸激酶活性的化合物的方法，作为用于心力衰竭治疗的潜在药物组合物。